Securing Gallium-68 availability with liquid target production on mid-energy cyclotrons: Users' experience and scaling up
Don’t miss the e-poster presentation at EANM : “Securing Gallium-68 availability with liquid target production on mid-energy cyclotrons: Users' experience and […]See more
ICNAS/University of Coimbra granted with first EU marketing authorization for the distribution of cyclotron produced Gallium-68
ICNAS/University of Coimbra granted with first EU marketing authorization for the distribution of cyclotron produced Gallium-68 The Institute of Nuclear […]See more
IBA and SCK CEN join forces to enable production of Actinium-225
Collaboration marks first step in evaluating the potential of the rapidly growing theranostics market Louvain-La-Neuve, Belgium, 15 September 2021 – […]See more
IBA Reports Half Year 2021 Results
25% SALES GROWTH AND STRONG IMPROVEMENT IN REBIT LINKED TO INCREASED ACTIVITY AND ACCELERATED BACKLOG CONVERSION STRONG BALANCE SHEET WITH […]See more
Rigging of the Cyclone® KIUBE for Inkor Technologies Co.
The Cyclone® KIUBE has reached its final position at Junqui in Foshan, China. The new radiopharmacy will be equipped with […]See more
A New Cyclone® KIUBE to be installed in Mogi das Cruzes, Brazil
R2IBF signed a contract with IBA for the company's new plant in Mogi das Cruzes to have the most modern […]See more
The Cyclone® KIUBE passed its acceptance test at Sichuan Province Cyclotron Medical Science Co., Ltd.
The new radiopharmacy will now be start its production of F-18 compounds using the Cyclone® KIUBE and the Synthera® + […]See more
The Cyclone® 70 for the Institute of Basic Science in Korea passed the Factory Acceptance Test.
The FAT confirms the machine is compliant with its specifications. The Cyclone® 70 will now be disassembled to be packed and […]See more
Our Newsletter is out! Issue 27, summer2021
The launch of the Cyclone® IKON, Cyclotron riggings, new members of the team, Synthera® installations, webinars,... read it all in our summer […]See more